{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:28:26Z","timestamp":1794853706514,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zambon SpA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12325-018-0687-z","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T14:52:48Z","timestamp":1521039168000},"page":"515-522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Long-term Efficacy of Safinamide on Parkinson\u2019s Disease Chronic Pain"],"prefix":"10.1007","volume":"35","author":[{"given":"Carlo","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Tubazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"687_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov Disord. 2011;26:399\u2013406.","journal-title":"Mov Disord"},{"key":"687_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrneurol.2012.54","volume":"8","author":"G Wasner","year":"2012","unstructured":"Wasner G, Deuschl G. Pains in Parkinson\u2019s disease: many syndromes under one umbrella. Nat Rev Neurol. 2012;8:284\u201394.","journal-title":"Nat Rev Neurol"},{"key":"687_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2008.12.004","volume":"141","author":"AG Beiske","year":"2009","unstructured":"Beiske AG, Loge JH, R\u00f8nningen A, Svennsson E. Pain in Parkinson\u2019s disease: prevalence and characteristics. Pain. 2009;141:173\u20137.","journal-title":"Pain"},{"issue":"1","key":"687_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/JPD-160911","volume":"7","author":"C Cattaneo","year":"2017","unstructured":"Cattaneo C, Barone P, Bonizzoni E, Sardina M. Effects of safinamide on pain in fluctuating Parkinson\u2019s disease patients: a post hoc analysis. J Parkinsons Dis. 2017;7(1):95\u2013101.","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"687_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/mds.25961","volume":"29","author":"R Borgohain","year":"2014","unstructured":"Borgohain R, Szasz J, Stanzione P, Meshram C, et al. Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson\u2019s disease. Mov Disord. 2014;29(10):1273\u201380.","journal-title":"Mov Disord"},{"issue":"2","key":"687_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mds.25751","volume":"29","author":"R Borgohain","year":"2014","unstructured":"Borgohain R, Szasz J, Stanzione P, Meshram C, et al. Randomized trial of safinamide add-on to levodopa in Parkinson\u2019s disease with motor fluctuations. Mov Disord. 2014;29(2):229\u201337.","journal-title":"Mov Disord"},{"key":"687_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s40263-012-0005-2","volume":"26","author":"S Munazza","year":"2012","unstructured":"Munazza S, Ford B. Management of pain in Parkinson\u2019s disease. CNS Drugs. 2012;26:937\u201348.","journal-title":"CNS Drugs"},{"key":"687_CR8","volume-title":"An essay on the shaking palsy","author":"J Parkinson","year":"1817","unstructured":"Parkinson J. An essay on the shaking palsy. London: Whittingham and Rowland; 1817."},{"key":"687_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.22142","volume":"23","author":"L N\u00e8gre-Pag\u00e8s","year":"2008","unstructured":"N\u00e8gre-Pag\u00e8s L, Regragui W, Bouhassira D, Grandjean H, Rascol O. DoPaMiP Study Group. Chronic pain in Parkinson\u2019s disease: the cross-sectional French DoPaMiP survey. Mov Disord. 2008;23:1361\u20139.","journal-title":"Mov Disord"},{"key":"687_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00415-012-6754-5","volume":"260","author":"A Truini","year":"2013","unstructured":"Truini A, Frontoni M, Cruccu G. Parkinson\u2019s disease related pain: a review of recent findings. J Neurol. 2013;260:330\u20134.","journal-title":"J Neurol"},{"key":"687_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00415-011-6202-y","volume":"259","author":"J Shearer","year":"2012","unstructured":"Shearer J, Green C, Counsell CE, Zajicek JP. The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson\u2019s disease. J Neurol. 2012;259:462\u20138.","journal-title":"J Neurol"},{"key":"687_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pain.2008.04.026","volume":"141","author":"C Brefel-Courbon","year":"2009","unstructured":"Brefel-Courbon C, Grolleau S, Thalams C, Bourrel L, et al. Comparison of chronic analgesic drugs prevalence in Parkinson\u2019s disease, other chronic diseases and the general population. Pain. 2009;141:14\u20138.","journal-title":"Pain"},{"key":"687_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ejp.745","volume":"20","author":"RG Cury","year":"2016","unstructured":"Cury RG, Galhardoni R, Fonoff ET, Perez Lloret S, et al. Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms. Eur J Pain. 2016;20:151\u201365.","journal-title":"Eur J Pain"},{"key":"687_CR14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1212\/WNL.0000000000004274","volume":"89","author":"M Nolano","year":"2017","unstructured":"Nolano M, Provitera V, Manganelli F, Iodice R, et al. Loss of cutaneous large and small fibers in na\u00efve and L-dopa treated PD patients. Neurology. 2017;89:776\u201384.","journal-title":"Neurology"},{"key":"687_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/jnnp.2005.079053","volume":"77","author":"M Tinazzi","year":"2006","unstructured":"Tinazzi M, Del Vesco C, Fincati E, Ottaviani S, Smania N, et al. Pain and motor complications in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2006;77:822\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"687_CR16","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1001\/archneurol.2008.2","volume":"65","author":"G Defazio","year":"2008","unstructured":"Defazio G, Berardelli A, Fabbrini G, Martino D, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol. 2008;65:1191\u20134.","journal-title":"Arch Neurol"},{"key":"687_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0304-3959(94)00172-B","volume":"60","author":"EH Chudler","year":"1995","unstructured":"Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain. 1995;60:3\u201338.","journal-title":"Pain"},{"issue":"12","key":"687_CR18","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s00415-009-0908-0","volume":"255","author":"HJ Kim","year":"2008","unstructured":"Kim HJ, Paek SH, Kim JY, Lee JY, et al. Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol. 2008;255(12):1889\u201394.","journal-title":"J Neurol"},{"key":"687_CR19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0022-3565(24)38068-1","volume":"288","author":"P Salvati","year":"1999","unstructured":"Salvati P, Maj R, Caccia C, Cervini MA, Fornaretto MG, et al. Biochemical and electrophysiological studies on the mechanism of action of PNU-151774E, a novel antiepileptic compound. J Pharmacol Exp Ther. 1999;288:1151\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.3390\/biom5043112","volume":"5","author":"T Miladinovic","year":"2015","unstructured":"Miladinovic T, Nashed MG, Sungh G. Overview of glutamatergic dysregulation in central pathologies. Biomolecules. 2015;5:3122\u201341.","journal-title":"Biomolecules"},{"issue":"5","key":"687_CR21","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.semcdb.2006.10.008","volume":"17","author":"D Bleakman","year":"2006","unstructured":"Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain. Semin Cell Dev Biol. 2006;17(5):592\u2013604.","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"687_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jcph.678","volume":"56","author":"O Rascol","year":"2016","unstructured":"Rascol O, Zesiewicz T, Chaudhuri KR, Ashgarnejad M, et al. A randomized controlled exploratory pilot study to evaluate the effect of rotigotine transdermal patch on Parkinson\u2019s disease-associated chronic pain. J Clin Pharm. 2016;56(7):852\u201361.","journal-title":"J Clin Pharm"},{"issue":"5","key":"687_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Shapira AH. Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8(5):464\u201374.","journal-title":"Lancet Neurol"},{"key":"687_CR24","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s40265-013-0105-4","volume":"73","author":"SH Fox","year":"2013","unstructured":"Fox SH. Non-dopaminergic treatments for motor control in Parkinson\u2019s disease. Drugs. 2013;73:1405\u201315.","journal-title":"Drugs"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0687-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-018-0687-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0687-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T20:04:39Z","timestamp":1751486679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-018-0687-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1007\/s12325-018-0687-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"30 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}